Viaspace, Inc. (VSPC)

[learner1156]

NEWS

VIASPACE Subsidiary DMFCC Receives Order for Formic Acid Fuel Cell Cartridges
Monday June 9, 8:30 am ET


PASADENA, Calif., June 9 /PRNewswire-FirstCall/ -- VIASPACE Inc. (OTC Bulletin Board: VSPC - News), a company that transforms proven space and defense technologies from NASA and the Department of Defense into hardware and software solutions, announced today that its Direct Methanol Fuel Cell Corporation (DMFCC) subsidiary has received an order from Lynntech Inc. of College Station, TX to design and produce formic acid fuel cell cartridges.
ADVERTISEMENT


CEO of VIASPACE and DMFCC, Dr. Carl Kukkonen, stated, "We are delighted to work with Lynntech. Our design team will design the fuel cell cartridge, pouch, and valve for a formic acid fuel cell, which will involve selection and testing of new materials suited to formic acid. This work is under a U.S. Army development contract in which the Army plans to use Lynntech's fuel cell combined with technology developed at Vanderbilt University to create a fuel cell system that has a minimum of moving parts and support structure to produce the complete power supply. The Army hopes that this combination will lead to a lightweight, rugged, reliable power supply suitable for use with either one time use disposable cartridges or bulk fuel."

Kukkonen continued, "Formic acid is also one of the liquids covered by our extensive license on fuel cell patents from Caltech, and it is also one of the types of fuel cells recently approved by the Department of Transportation for crew and passengers to carry on board commercial aircraft."

About VIASPACE: Founded in 1998 with the objective of transforming proven space and defense technologies from NASA and the Department of Defense into hardware and software solutions that solve today's complex problems, VIASPACE benefits from important patent and software licenses from Caltech, which manages NASA's Jet Propulsion Laboratory. For more information, please see http://www.VIASPACE.com, or contact Dr. Jan Vandersande, Director of Communications at 800-517-8050, or [e-mail].